Maximum quantity allowed is 999
Please select the quantity
CAS RN: 212322-56-0 | Product Number: E1033
Ethyl 3-[3-Amino-4-(methylamino)-N-(2-pyridyl)benzamido]propionate
![Ethyl 3-[3-Amino-4-(methylamino)-N-(2-pyridyl)benzamido]propionate Chemical Structure of Ethyl 3-[3-Amino-4-(methylamino)-N-(2-pyridyl)benzamido]propionate](/medias/E1033.jpg?context=bWFzdGVyfHJvb3R8NDEwNjR8aW1hZ2UvanBlZ3xhREJpTDJnMU5TODRPVEl4TmpFNE56RXdOVFU0TDBVeE1ETXpMbXB3Wnd8NmU1YTNkOWVlYmI2MjkyYjQwMGIxNjU4MmZiNmJmYjAxNDgxODZhYTRiMmVjOTc3NDQxMGQwNDZlYzczNjJlYg)
Purity: >98.0%(T)(HPLC)
Synonyms:
- 3-[3-Amino-4-(methylamino)-N-(2-pyridyl)benzamido]propionic Acid Ethyl Ester
Product Documents:
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Product Number | E1033 |
Purity / Analysis Method ![]() |
>98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__8H__2__2N__4O__3 = 342.40 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 212322-56-0 |
Reaxys Registry Number | 9147567 |
PubChem Substance ID | 253661756 |
MDL Number | MFCD09833624 |
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Melting point | 104.0 to 108.0 °C |
Properties (reference)
Melting Point | 106 °C |
Solubility (soluble in) | Methanol |
GHS
Related Laws:
Transport Information:
H.S.code* | 2933.39-000 |
Application
A Synthetic Intermediate of Dabigatran and Its Derivatives
This product has been used as a synthetic intermediate of dabigatran [D5902, D5904 (Etexilate)] and its derivatives, which are direct thrombin inhibitors.
References
- Structure-based design of novel potent nonpeptide thrombin inhibitors
- Synthesis, characterization and suppression of impurities during optimization of Dabigatran etexilate
- Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors
- Gradient RP-HPLC method for the determination of potential impurities in dabigatran etexilate in bulk drug and capsule formulations
PubMed Literature
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.